DWI as an Imaging Biomarker for Bladder Cancer

被引:57
作者
Yoshida, Soichiro [1 ]
Takahara, Taro [2 ]
Kwee, Thomas C. [3 ]
Waseda, Yuma [1 ]
Kobayashi, Shuichiro [4 ]
Fujii, Yasuhisa [1 ]
机构
[1] Tokyo Med & Dent Univ, Grad Sch, Dept Urol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan
[2] Tokai Univ, Dept Biomed Engn, Sch Engn, Hiratsuka, Kanagawa, Japan
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands
[4] Tama Nambu Chiiki Hosp, Dept Urol, Tokyo, Japan
关键词
biomarker; DWI; MRI; urinary bladder neoplasms; DIFFUSION-WEIGHTED MRI; PELVIC LYMPH-NODES; URINARY-BLADDER; ADC VALUES; EAU GUIDELINES; CELL CARCINOMA; EARLY RESPONSE; BODY; DIAGNOSIS; CHEMORADIOTHERAPY;
D O I
10.2214/AJR.17.17798
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. DWI has been increasingly applied in the management of bladder cancer. In this article, we discuss the role of DWI as an imaging biomarker for bladder cancer. CONCLUSION. The DWI signal is derived from the motion of water molecules, which represents the physiologic characteristics of the tissue of interest. The emerging evidence highlights the utility of DWI for bladder cancer detection and characterization. DWI is a potentially useful tool to individualize treatment strategies.
引用
收藏
页码:1218 / 1228
页数:11
相关论文
共 78 条
[1]   Bladder Cancer: Diagnosis with Diffusion-weighted MR Imaging in Patients with Gross Hematuria [J].
Abou-El-Ghar, Mohamed E. ;
El-Assmy, Ahmed ;
Refaie, Huda F. ;
El-Diasty, Tarek .
RADIOLOGY, 2009, 251 (02) :415-421
[2]   Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT [J].
Alongi, Pierpaolo ;
Caobelli, Federico ;
Gentile, Roberta ;
Stefano, Alessandro ;
Russo, Giorgio ;
Albano, Domenico ;
Baldari, Sergio ;
Gilardi, Maria Carla ;
Midiri, Massimo .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (02) :224-233
[3]   Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations [J].
不详 .
NEOPLASIA, 2009, 11 (02) :102-125
[4]  
[Anonymous], RADIOLOGY
[5]   Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].
Atkinson, AJ ;
Colburn, WA ;
DeGruttola, VG ;
DeMets, DL ;
Downing, GJ ;
Hoth, DF ;
Oates, JA ;
Peck, CC ;
Schooley, RT ;
Spilker, BA ;
Woodcock, J ;
Zeger, SL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95
[6]   The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions [J].
Avcu, S. ;
Koseoglu, M. N. ;
Ceylan, K. ;
Dbulutand, M. ;
Unal, O. .
BRITISH JOURNAL OF RADIOLOGY, 2011, 84 (1006) :875-882
[7]   EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 [J].
Babjuk, Marko ;
Burger, Maximilian ;
Zigeuner, Richard ;
Shariat, Shahrokh F. ;
van Rhijn, Bas W. G. ;
Comperat, Eva ;
Sylvester, Richard J. ;
Kaasinen, Eero ;
Boehle, Andreas ;
Palou Redorta, Joan ;
Roupret, Morgan .
EUROPEAN UROLOGY, 2013, 64 (04) :639-653
[8]   Basic principles of diffusion-weighted imaging [J].
Bammer, R .
EUROPEAN JOURNAL OF RADIOLOGY, 2003, 45 (03) :169-184
[9]   Relation of apparent diffusion coefficient with Ki-67 proliferation index in meningiomas [J].
Baskan, Ozdil ;
Silav, Gokalp ;
Bolukbasi, Fatih Han ;
Canoz, Ozlem ;
Geyik, Serdar ;
Elmaci, Ilhan .
BRITISH JOURNAL OF RADIOLOGY, 2016, 89 (1057)
[10]   Combined Ultrasmall Superparamagnetic Particles of Iron Oxide-Enhanced and Diffusion-weighted Magnetic Resonance Imaging Facilitates Detection of Metastases in Normal-sized Pelvic Lymph Nodes of Patients with Bladder and Prostate Cancer [J].
Birkhaeuser, Frederic D. ;
Studer, Urs E. ;
Froehlich, Johannes M. ;
Triantafyllou, Maria ;
Bains, Lauren J. ;
Petralia, Giuseppe ;
Vermathen, Peter ;
Fleischmann, Achim ;
Thoeny, Harriet C. .
EUROPEAN UROLOGY, 2013, 64 (06) :953-960